1. From Cardiovascular Engineering, Inc, Holliston, Mass (G.F.M.); Centre hospitalier de l’Universite Laval, Ste Foy, Quebec, Canada (Y.L.); Q&T Research, Inc, Sherbrooke, Quebec, Canada (J.-P.O.); State University of New York at Buffalo, Buffalo, NY (J.L.I.); Orange County Research Center, Orange, Calif (J.N.); Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ (L.J.K., A.J.B.); and Brigham and Women’s Hospital, Boston, Mass (M.A.P.).